Intrathoracic manifestations in non-Hodgkin's lymphoma

Area of Science:

• Oncology
• Pulmonology
• Radiology

Background:

• Non-Hodgkin's lymphoma is a significant hematologic malignancy.
• Intrathoracic involvement in lymphoma can impact staging and treatment.
• Understanding patterns of intrathoracic disease is crucial for patient management.

Purpose of the Study:

• To determine the frequency and patterns of intrathoracic disease in non-Hodgkin's lymphoma.
• To analyze the clinical stage and presentation of intrathoracic lymphoma.
• To evaluate the impact of intrathoracic disease on treatment response and prognosis.

Main Methods:

• Retrospective analysis of 86 patients with non-Hodgkin's lymphoma.
• Review of imaging findings to identify intrathoracic manifestations.
• Correlation of intrathoracic disease with clinical stage, treatment, and outcomes.

Main Results:

• 16 out of 86 patients (19%) had intrathoracic disease.
• Common presentations included paratracheal, mediastinal, hilar lymphadenopathy, pulmonary lesions, and pleural effusion.
• All patients with intrathoracic disease had advanced clinical stage lymphoma.
• One-third of intrathoracic lesions occurred at relapse.
• Initial presentation of intrathoracic disease showed better treatment response than relapse.
• Lack of response to therapy indicated a poor prognosis.

Conclusions:

• Intrathoracic disease is a notable finding in advanced non-Hodgkin's lymphoma.
• The timing of intrathoracic disease presentation (initial vs. relapse) influences therapeutic outcomes.
• Intrathoracic lymphoma unresponsive to treatment is associated with a poor prognosis.